Genistein and daidzein induce ferroptosis in MDA-MB-231 cells
Makaleler > Tam Makale · 2024
Yazarlar: Ege ARZUK, Güliz ARMAGAN
JOURNAL OF PHARMACY AND PHARMACOLOGY, SCI İndekslerine Giren Dergi, Uluslararası, Wos, 2024, ss 1599-1608
DOI: 10.1093/jpp/rgae106
Özet
Objectives In recent years, there has been a growing interest in targeting ferroptosis for the treatment and prevention of multiple cancers. This study aimed to assess the contribution of ferroptosis to the antiproliferative effects of genistein (GN) and daidzein (DZ) in breast cancer cell lines.Methods MDA-MB-231 and MCF-7 cells were employed as an in vitro model. The antiproliferative effects of GN and DZ were determined by WST-1 assay in the presence of specific inhibitors of different cell death pathways. The mRNA expressions of Gpx4 and Fsp-1, the levels of lipid peroxidation, glutathione (GSH)/glutathione disulfide (GSSG) ratio, and intracellular iron ion content were assessed in GN- or DZ-treated cells.Results GN and DZ were found to cause ferroptotic cell death in MDA-MB-231, as confirmed by the reversal of viability when cells were pretreated with ferrostatin-1. Furthermore, both phytochemicals induced biochemical markers of ferroptosis, including lipid peroxidation and iron ions levels, and decreased GSH/GSSG levels. The mRNA expression levels of the main anti-ferroptotic genes, Gpx4 and Fsp-1, were diminished by the treatment of both phytochemicals. Surprisingly, ferroptosis did not play a role in GN- or DZ-induced cell death in MCF-7 cells.Conclusion Our findings highlight the potential of GN and DZ as ferroptosis inducers in triple-negative breast cancer cells.